19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Antonio Ascierto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Biology confirmed but biomarkers elusive in melanoma immunotherapy

Luke, J. J. & Ascierto, P. A., Jan 1 2020, (Accepted/In press) In : Nature Reviews Clinical Oncology.

Research output: Contribution to journalComment/debate

CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer

Cerbelli, B., Botticelli, A., Pisano, A., Pernazza, A., Campagna, D., De Luca, A., Ascierto, P. A., Pignataro, M. G., Pelullo, M., Rocca, C. D., Marchetti, P., Fortunato, L., Costarelli, L. & d’Amati, G., 2020, (Accepted/In press) In : Virchows Archiv.

Research output: Contribution to journalArticle

  • Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

    Marabelle, A., Le, D. T., Ascierto, P. A., Di Giacomo, A. M., De Jesus-Acosta, A., Delord, J. P., Geva, R., Gottfried, M., Penel, N., Hansen, A. R., Piha-Paul, S. A., Doi, T., Gao, B., Chung, H. C., Lopez-Martin, J., Bang, Y. J., Frommer, R. S., Shah, M., Ghori, R., Joe, A. K. & 2 others, Pruitt, S. K. & Diaz, L. A., Jan 1 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 1, p. 1-10 10 p.

    Research output: Contribution to journalArticle

  • Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

    Cortellini, A., Buti, S., Bersanelli, M., Giusti, R., Perrone, F., Di Marino, P., Tinari, N., De Tursi, M., Grassadonia, A., Cannita, K., Tessitore, A., Zoratto, F., Veltri, E., Malorgio, F., Russano, M., Anesi, C., Zeppola, T., Filetti, M., Marchetti, P., Botticelli, A. & 29 others, Cappellini, G. C. A., De Galitiis, F., Vitale, M. G., Rastelli, F., Pergolesi, F., Berardi, R., Rinaldi, S., Tudini, M., Silva, R. R., Pireddu, A., Atzori, F., Iacono, D., Migliorino, M. R., Gelibter, A., Occhipinti, M. A., Martella, F., Inno, A., Gori, S., Bracarda, S., Zannori, C., Mosillo, C., Parisi, A., Porzio, G., Mallardo, D., Fargnoli, M. C., Tiseo, M., Santini, D., Ascierto, P. A. & Ficorella, C., Jan 1 2020, In : OncoImmunology. 9, 1, 1710389.

    Research output: Contribution to journalArticle

    Open Access
  • Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients

    Capone, M., Fratangelo, F., Giannarelli, D., Sorrentino, C., Turiello, R., Zanotta, S., Galati, D., Madonna, G., Tuffanelli, M., Scarpato, L., Grimaldi, A. M., Esposito, A., Azzaro, R., Pinto, A., Cavalcanti, E., Pinto, A., Morello, S. & Ascierto, P. A., Mar 11 2020, In : Journal of Translational Medicine. 18, 1, 1 p.

    Research output: Contribution to journalArticle

    Open Access